These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10446226)

  • 1. Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.
    Martín B; Vaquero A; Priebe W; Portugal J
    Nucleic Acids Res; 1999 Sep; 27(17):3402-9. PubMed ID: 10446226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the effects of daunorubicin and WP631 on transcription.
    Portugal J; Martín B; Vaquero A; Ferrer N; Villamarín S; Priebe W
    Curr Med Chem; 2001 Jan; 8(1):1-8. PubMed ID: 11172687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1-targeted inhibition of gene transcription by WP631 in transfected lymphocytes.
    Mansilla S; Priebe W; Portugal J
    Biochemistry; 2004 Jun; 43(23):7584-92. PubMed ID: 15182200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp1 transcription factor as a target for anthracyclines: effects on gene transcription.
    Mansilla S; Portugal J
    Biochimie; 2008 Jul; 90(7):976-87. PubMed ID: 18226599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of basal and transforming growth factor-beta-induced stimulation of COL1A1 transcription by the DNA intercalators, mitoxantrone and WP631, in cultured human dermal fibroblasts.
    Gaidarova S; Jiménez SA
    J Biol Chem; 2002 Oct; 277(41):38737-45. PubMed ID: 12138160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region.
    Nair RR; Wang H; Jamaluddin MS; Fokt I; Priebe W; Boyd DD
    Oncol Res; 2005; 15(5):265-79. PubMed ID: 16261846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of a new bisintercalating anthracycline antibiotic.
    Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
    J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gene expression induced by Sp1 knockdown differ from those caused by challenging Sp1 binding to gene promoters.
    Mansilla S; Priebe W; Portugal J
    Biochim Biophys Acta; 2011 Jul; 1809(7):327-36. PubMed ID: 21684359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel clustering of Sp1 transcription factor binding sites at the transcription initiation site of the human muscle phosphofructokinase P1 promoter.
    Johnson JL; McLachlan A
    Nucleic Acids Res; 1994 Nov; 22(23):5085-92. PubMed ID: 7800504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity.
    Wang X; Talamantez JL; Adamo ML
    Endocrinology; 1998 Mar; 139(3):1054-66. PubMed ID: 9492038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes.
    Villamarín S; Ferrer-Miralles N; Mansilla S; Priebe W; Portugal J
    Biochem Pharmacol; 2002 Apr; 63(7):1251-8. PubMed ID: 11960601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter.
    Gu B; Rivera-Gonzalez R; Smith CA; DeLuca NA
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9528-32. PubMed ID: 8415735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new bisintercalating anthracycline with picomolar DNA binding affinity.
    Portugal J; Cashman DJ; Trent JO; Ferrer-Miralles N; Przewloka T; Fokt I; Priebe W; Chaires JB
    J Med Chem; 2005 Dec; 48(26):8209-19. PubMed ID: 16366602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of DNA-protein interactions in the P1 and P2 c-myc promoters by two intercalating drugs.
    Vaquero A; Portugal J
    Eur J Biochem; 1998 Jan; 251(1-2):435-42. PubMed ID: 9492315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo.
    Blume SW; Snyder RC; Ray R; Thomas S; Koller CA; Miller DM
    J Clin Invest; 1991 Nov; 88(5):1613-21. PubMed ID: 1834700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells.
    Liu Z; Simpson ER
    Mol Endocrinol; 1997 Feb; 11(2):127-37. PubMed ID: 9013760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific in vivo protein-DNA interactions at the promoter region of the Xenopus 63 kDa keratin gene during metamorphosis.
    Warshawsky D; Miller L
    Nucleic Acids Res; 1995 Nov; 23(21):4502-9. PubMed ID: 7501476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a DNA-bisdaunomycin complex.
    Hu GG; Shui X; Leng F; Priebe W; Chaires JB; Williams LD
    Biochemistry; 1997 May; 36(20):5940-6. PubMed ID: 9166763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy.
    Robinson H; Priebe W; Chaires JB; Wang AH
    Biochemistry; 1997 Jul; 36(29):8663-70. PubMed ID: 9289011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein interactions at Sp1-like sites in the TGF alpha promoter as visualized by in vivo genomic footprinting.
    Chen X; Wright KL; Berkowitz EA; Azizkhan JC; Ting JP; Lee DC
    Oncogene; 1994 Nov; 9(11):3179-87. PubMed ID: 7936640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.